Patents Assigned to Canyon Pharmaceuticals, Inc.
  • METHODS FOR EFFECTING REGRESSION OF TUMOR MASS AND SIZE IN A METASTASIZED TUMOR
    Publication number: 20110224150
    Abstract: The present invention relates generally to methods of effecting regression of tumor size and mass of a metastasized tumor in a subject by administering an effective amount of a desulphatohirudin variant.
    Type: Application
    Filed: September 13, 2010
    Publication date: September 15, 2011
    Applicant: CANYON PHARMACEUTICALS, INC.
    Inventor: Cheng-Der Tony YU
  • Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
    Patent number: 7795205
    Abstract: The present invention relates generally to methods of inhibiting angiogenesis in a patient by administering an effective angiogenesis-inhibiting amount of a thrombin inhibitor, and to the treatment of disease states that result from uncontrolled cell proliferation by administering a thrombin inhibitor alone or co-administering a thrombin inhibitor with an anticancer or cytotoxic agent. Specifically, the thrombin inhibitors used in the methods of the present invention are hirudins.
    Type: Grant
    Filed: April 4, 2005
    Date of Patent: September 14, 2010
    Assignee: Canyon Pharmaceuticals, Inc.
    Inventor: Cheng-Der Tony Yu